Open AccessReverse hybrid therapy achieves a similar eradication rate as standard hybrid therapy for Helicobacter pylori infection
Author(s) -
Te-Fu Lin,
DengChyang Wu,
FengWoei Tsay,
KuoWang Tsai,
TzungJiun Tsai,
NanJing Peng,
SungShuo Kao,
WenChi Chen,
Yanhua Chen,
PingI Hsu
Publication year - 2020
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000256
Subject(s) - medicine , metronidazole , clarithromycin , helicobacter pylori , amoxicillin , proton pump inhibitor , gastroenterology , combination therapy , antibiotics , microbiology and biotechnology , biology
Reverse hybrid therapy is a simplified hybrid treatment for Helicobacter pylori infection. It achieves a higher eradication rate than standard triple therapy. This study aimed to compare the efficacies of reverse hybrid and hybrid therapies in the treatment of H. pylori infection.